Abstract
The area of antiulcer research has changed dramatically over the past three years due to the introduction of proton pump inhibitors and the discovery of the link between Helicobacter pylori and peptic ulcer disease. Established agents such as ranitidine and famotidine have secured their place in the world market, but a number of novel agents are currently under investigation and could lead to new therapies in the future. This article reviews the the existing treatments available and their side effects, whilst briefly discussing the new compounds which have been disclosed in the recent patent literature.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
